US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,834.82

+26.851.49%

Number of Gainers:8

Number of Losers:11

Number of Flat:- -

PE:- -

High:1,846.22

Open:1,807.96

Low:1,807.96

Close:1,807.97

Volume:93.98M

Turnover:7.41B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares

Vir to Present Expanded Phase 2 Solstice Data on Elebsiran-Tobevibart Combo in Hepatitis Delta at AASLD 2026

Equillium Wins Australian Regulatory Clearance for EQ504 Phase 1 Trial

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

THOMSON REUTERS

Equillium - Expects to Begin Dosing by Early November 2026

THOMSON REUTERS

Equillium - Topline Phase 1 Data Expected Six Months After Study Initiation

THOMSON REUTERS

Abbott Laboratories Stock (ABT) Moved Up by 3.08% on Oct 5: Facts Behind the Movement

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live

Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know

AstraZeneca to Invest Over $1 Billion in Massachusetts

MT Newswires Live

AstraZeneca to Invest over $1 Billion in Massachusetts, Boost Workforce

AstraZeneca opens R&D center in Cambridge, Massachusetts

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Cboe data shows mixed options sentiment in Moderna with shares up 0.52%

Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor

MT Newswires Live

Abbott - Cardioguide HF App and Dynamic Treatment Plan to be Available Later This Year

THOMSON REUTERS

NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’

NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Bundibugyo Ebola in DRC

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Genmab (GMAB)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4568/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1834.8213,"timestamp":1791403199999,"preClose":1807.9673,"halted":0,"volume":93984772,"delay":0,"changeRate":0.014853,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":26.854004,"latestTime":"10-07 16:00:00 EDT","open":1807.9589,"high":1846.2249,"low":1807.9589,"amount":7406821698.784554,"amplitude":0.021165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.738387,"peRate":45.966788,"turnoverRate":0.006774,"increases":8,"decrements":11,"flats":0,"marketCap":1491961574063,"floatMarketCap":1456681952673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1846.2249,"amplitude":0.021165,"preClose":1807.9673,"low":1807.9589,"pbRate":"4.738387","latestPrice":1834.8213,"volume":93984772,"delay":0,"open":1807.9589,"prevYearClose":1637.1339,"prevWeekClose":1811.1105,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1862.664,"twentyDayClose":1835.2891,"sixtyDayClose":1685.2764,"secType":"PLATE","market":"US","turnoverRate":0.006774,"peRate":45.966788,"marketCap":1491961574063,"floatMarketCap":1456681952673,"timestamp":1791403199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1778281490.HKD","IDNA","BK4551","IE00B19Z3B42.SGD","MRNY","IBBQ","LU0861579265.USD","BK4585","LU0965509101.SGD","LU1934455277.USD","LU2087621335.USD","BK4588","BK4578","BK4533","LU1839511570.USD","BK4139","LU1057294990.SGD","SG9999015945.SGD","LGHT","LU1674673691.USD","TBXU","BIB","MEDI","LU1066051498.USD","LU2357627491.SGD","BK4568","BK4532","BBH","IBB","LU1037948897.HKD","GILD","GNOM","MRNA","BK4583","LU1674673428.USD","TMED","IE00B7SZLL34.SGD","LU1061106388.HKD","LU0965509010.AUD","LU2324357040.USD","LU0823416689.USD","SG9999015952.SGD","IE00BZ1G4Q59.USD","MRNX","WDNA","BMED","LU0109394709.USD","LU2112291526.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673817430","title":"Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673817430","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673817430?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:11","pubTimestamp":1791231084,"startTime":"0","endTime":"0","summary":"Aethlon Medical says shareholders reject proposal to authorize 20,000,000 preferred sharesAethlon Medical filed an amended 8-K to correct its prior disclosure on a shareholder vote at the 2026 annual ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL6k3Z0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4583","BK4568","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673294081","title":"Vir to Present Expanded Phase 2 Solstice Data on Elebsiran-Tobevibart Combo in Hepatitis Delta at AASLD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673294081","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673294081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230793,"startTime":"0","endTime":"0","summary":"Vir to present expanded Phase 2 SOLSTICE data on elebsiran-tobevibart combo in hepatitis delta at AASLD 2026Vir Biotechnology flagged expanded Phase 2 SOLSTICE results for elebsiran with tobevibart in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL8gq1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4568","BK4139","BK4585","VIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081295","title":"Equillium Wins Australian Regulatory Clearance for EQ504 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081295","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081295?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230773,"startTime":"0","endTime":"0","summary":"Equillium wins Australian regulatory clearance for EQ504 Phase 1 trialEquillium secured Australian TGA clearance under the CTN scheme to start a first-in-human Phase 1 trial of EQ504.HREC approval rec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL38Vpw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","EQ","BK4139","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","BK4568","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BQXX3C00.GBP","SG9999014039.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081474","title":"Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081474?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EQ","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081268","title":"Equillium - Expects to Begin Dosing by Early November 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081268?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081219","title":"Equillium - Topline Phase 1 Data Expected Six Months After Study Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081219?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089667","title":"Abbott Laboratories Stock (ABT) Moved Up by 3.08% on Oct 5: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089667","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089667?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:15","pubTimestamp":1791224127,"startTime":"0","endTime":"0","summary":"• Abbott secured FDA approval for its CardioMEMS heart failure system features.\n• The company reported annual revenue of $44.33B with net profit of $6.52B.\n• Analysts issued Buy ratings with an average price target of $121.29.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20240312/739560ea1773ec262fcbb9f39bcda151.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20240312/739560ea1773ec262fcbb9f39bcda151.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262200611-market-movers-abt-20261005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4568","LU2468319806.SGD","LU0211331839.USD","IE0009355771.USD","LU1721429402.USD","LU2211815571.USD","SG9999004303.SGD","LU1691799644.USD","LU0208291251.USD","LU1670628061.USD","LU1989763690.USD","ABT","LU1670627923.USD","SG9999002232.USD","SGXZ23171101.USD","IE00B4R5TH58.HKD","IHI","BK4585","BK4588","BK4504","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU2237957811.SGD","BK4533","LU0170899867.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU0289739699.SGD","LU0320765489.SGD","LU1061106388.HKD","LU1989763427.SGD","LU0070302665.USD","LU0882574055.USD","SG9999002224.SGD","LU1914381329.SGD","PJP","TMED","BK4566","IE00BFTCPJ56.SGD","LU2237957902.USD","LU0058720904.USD","LU2133065610.SGD","LU0234572021.USD","SGXZ41872573.SGD","LU0432979614.USD","LU0122379950.USD","LU2324357040.USD","LU1983299246.USD","LU2089984988.USD","LU0114720955.EUR","LU1721429741.USD","BK4082","LU0868494617.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673860230","title":"Sector Update: Healthcare Stocks Rise Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2673860230","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673860230?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:42","pubTimestamp":1791222136,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index rising 0.4% and the State Street Health Care Select Sector SPDR ETF  adding 0.5%.The iShares Biotechnology ETF  advanced 0.7%.In corporate news, GE HealthCare Technologies  said it has agreed to buy Sofie Biosciences from private equity firm Trilantic North America for $945 million. Shares rose 1.5%.AstraZeneca  said Monday it is investing over $1 billion in Massachusetts as part of its broader investment of $50 billion across the US. Its shares were down 0.4%.UnitedHealth  is being investigated by Texas Attorney General Ken Paxton over allegations that it has engaged in \"deceptive\" and \"unlawful\" practices that denied Texans access to medically necessary healthcare, the AG said Monday. UnitedHealth shares eased 0.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2361044865.SGD","LU0211326839.USD","SG9999017495.SGD","IXJ","IHF","LU1720051017.SGD","LU0553294199.USD","IE00B4JS1V06.HKD","LU1066053197.SGD","LU0353189763.USD","LU2999663052.SGD","LU1035773651.USD","LU0820561909.HKD","LU1037948897.HKD","LU0211328371.USD","LU1718418525.SGD","LU0143551892.USD","LU1003077747.HKD","LU1674673691.USD","IE00B19Z3581.USD","LU2111349929.HKD","LU1983299246.USD","UNH","VHT","LU1267930227.SGD","LU0342679015.USD","LU0310799852.SGD","LU1261432733.SGD","LU1791710400.SGD","LU0238689110.USD","IE00BZ9MQY76.HKD","LU0109391861.USD","IE00B19Z8X17.USD","LU0557290698.USD","LU2552382215.SGD","LU0345770308.USD","IE0009355771.USD","IE00BWXC8680.SGD","LU0109394709.USD","LU2362540622.SGD","LU2125154935.USD","GDOC","BK4007","IYH","LU2089284900.SGD","LU0094547139.USD","SG9999014898.SGD","LU2237443978.SGD","LU2236285917.USD","LU0795875169.SGD","UNHW","LU1934455277.USD","LU0820562030.AUD","LU2491050071.SGD","LU1069347547.HKD","SG9999001176.USD","IE00B1BXHZ80.USD","LU1074936037.SGD","LU1720051108.HKD","LU0889565916.HKD","LU1814569148.SGD","LU0882574055.USD","LU0158827948.USD","LU2324357040.USD","LU2361045086.USD","LU0320765992.SGD","LU1066051498.USD","LU1153585028.USD","TRUH","LU0011850046.USD","LU0114720955.EUR","IE00BFSS7M15.SGD","LU1791710582.SGD","LU2279689827.SGD","SGXZ31699556.SGD","LU1551013342.USD","BK4566","LU2242649171.HKD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU1854104046.USD","LU0052756011.USD","LU0187121727.USD","IE00B3T34201.USD","SG9999018857.SGD","LU1732799900.SGD","LU0943347566.SGD","LU0861579265.USD","LU1989771016.USD","SG9999014906.USD","LU2491049909.HKD","XLV","LU2271345857.HKD","LU0058720904.USD","LU0823416689.USD","LU0661504455.SGD","LU1267930730.SGD","BK4588","LU1061106388.HKD","LU2023251221.USD","LU2552382132.HKD","LU0965508806.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0122379950.USD","LU0354030511.USD","LU0496365809.HKD","LU1267930573.SGD","LU1119994496.HKD","LU2237443549.SGD","LU2125154778.USD","LU2244417387.USD","LU2237443622.USD","LU0689472784.USD","LU2462157665.USD","LU0256863811.USD","LU0124676726.USD","LU0545039389.USD","IE00BJT1NW94.SGD","LU1914381329.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU0107464264.USD","LU0128525929.USD","IE00B7KXQ091.USD","LU0149725797.USD","LU0158827781.USD","LU0738911758.USD","LU0965509010.AUD","LU2461242641.AUD","JDOC","IE00BFXG1179.USD","LU0310800965.SGD","LU1674673428.USD","LU1670627923.USD","AZN","LU2089283258.USD","LU0211327993.USD","LU1506573853.SGD","LU2237443382.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00B19Z9505.USD","LU0787776722.HKD","LU2362541273.HKD","LU2552382058.USD","UNHU","LU1323610961.USD","LU0708995401.HKD","LU1732800096.USD","LU1854103824.USD","SG9999018865.SGD","LU0198837287.USD","LU0251132253.USD","LU2264538146.SGD","IE00BKPKM429.USD","LU1551013425.SGD","SG9999014880.SGD","IE0002270589.USD","LU1037948541.HKD","LU0432979614.USD","LU2112291526.USD","IBB","LU0795875086.SGD","LU0316494557.USD","BK4534","IE00B19Z9P08.USD","LU2462591277.SGD","RXL","LU0162691827.USD","SGXZ99366536.SGD","BK4581","LU0289739699.SGD","SG9999002224.SGD","XBI","FHLC","LU2456880835.USD","LGHT","LU0203347892.USD","UN","LU0689626769.HKD","LU2237443895.HKD","LU1934455863.HKD","LU0128525689.USD","LU2468319806.SGD","IE00B19Z8W00.USD","LU0048584097.USD","LU0029864427.USD","LU1066051811.HKD","LU2360032135.SGD","MHIP","LU2954938101.SGD","LABU","LU0345770993.USD","LU0965509283.SGD","IE00B775H168.HKD","LU0203345920.USD","LU0683600562.USD","SUNH0main","IE00BJJMRX11.SGD","LU0077335932.USD","LU2133065610.SGD","TMED","BK4154","LU0320765059.SGD","SG9999001176.SGD","IE0004445015.USD","LU0097036916.USD","LU1670628061.USD","IE00BSNM7G36.USD","LU2491050154.USD","LU2347655156.SGD","BK4568","LU1064131342.USD","LU0353189680.USD","LU0672654240.SGD","LU2089984988.USD","GEHC","LU1548497426.USD","BK4082","LU0354030438.USD","LU0266013472.USD","LU1778281490.HKD","LU1084165304.USD","SG9999002232.USD","IE00B1XK9C88.USD","AZNH","SGXZ81514606.USD","BK4585","LU1267930490.SGD","LU0949170772.SGD","LU0708994859.HKD","LU0820561818.USD","IE0002141913.USD","BK4533","IE00B894F039.SGD","IE00BN29S564.USD","LU2028103732.USD","HRTS","LU2357305700.SGD","LU2361044949.HKD","LU2362541513.USD","IE00B7SZLL34.SGD","LU2211815571.USD","LU1066051225.USD","LU0079474960.USD","LU0211326755.USD","LU0456855351.SGD","LU0072461881.USD","SGXZ51526630.SGD","LU1057294990.SGD","LU2417539215.USD","LU0528227936.USD","LU1934455194.USD","IE00BJJMRY28.SGD","LU0417517546.SGD","LU1291159041.SGD","IE00B19Z9Z06.USD","LU0053666078.USD","LU1496350502.SGD","LU0912757837.SGD","LU1988902786.USD","SG9999013999.USD","IE000M9KFDE8.USD","LU0234572021.USD","LU1829250122.USD","LU2237443465.HKD","IE00BFSS8Q28.SGD","BK4532","IE00B19Z3B42.SGD","IE0005OL40V9.USD","LU1023059063.AUD","LU2087625088.SGD","UNHG","IE00BKVL7J92.USD","SG9999014914.USD","LU0976567544.SGD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089818","title":"Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089818","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089818?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:15","pubTimestamp":1791220527,"startTime":"0","endTime":"0","summary":"• Moderna joins the Nasdaq-100 Index, driving institutional portfolio rebalancing and share accumulation.\n• Optimism for the Merck partnershiped oncology pipeline boosts long-term investor market sentiment.\n• The company reported an annual revenue of $1.94B and net profit of $-2.82B.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262200511-market-movers-mrna-20261005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","GNOM","BK4533","BK4548","IDNA","MRNA","MRNX","MRNY","BK4534","BK4551","BK4532","BK4568","BK4501","BK4139","BK4588","BK4585","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673408647","title":"AstraZeneca to Invest Over $1 Billion in Massachusetts","url":"https://stock-news.laohu8.com/highlight/detail?id=2673408647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673408647?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:08","pubTimestamp":1791220083,"startTime":"0","endTime":"0","summary":"Price: 156.19, Change: -0.71, Percent Change: -0.45","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443978.SGD","LU2468319806.SGD","IE00B3T34201.USD","LU2417539215.USD","LU0289739699.SGD","LU2236285917.USD","LU0128525929.USD","LU0320765992.SGD","BK4568","LU1267930573.SGD","LU2456880835.USD","LU0432979614.USD","LU0029864427.USD","AZNH","LU2237443622.USD","LU0708994859.HKD","LU2237443895.HKD","LU2237443549.SGD","BK4585","BK4007","LU2237443465.HKD","LU2462157665.USD","BK4588","LU0889565916.HKD","LU0109394709.USD","LU0310800379.SGD","LU0058720904.USD","LU2089984988.USD","LU2237443382.USD","LU1829250122.USD","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673602086","title":"AstraZeneca to Invest over $1 Billion in Massachusetts, Boost Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2673602086","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673602086?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:47","pubTimestamp":1791218871,"startTime":"0","endTime":"0","summary":"UPDATE 1-AstraZeneca to invest over $1 billion in Massachusetts, boost workforceOct 5 (Reuters)-AstraZenecaAZN.Lsaid on Monday it would spend more than $1 billion in Massachusetts as part of its broad","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R11Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU2237443549.SGD","AZN","LU2089984988.USD","BK4585","LU0708994859.HKD","BK4588","BK4007","LU2237443895.HKD","LU0889565916.HKD","IE00B3T34201.USD","LU2237443382.USD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","LU2237443622.USD","LU0128525929.USD","AZNH","LU1267930573.SGD","BK4568","LU2468319806.SGD","LU0029864427.USD","LU2237443465.HKD","LU0310800379.SGD","LU2456880835.USD","LU0289739699.SGD","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","LU0058720904.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673108686","title":"AstraZeneca opens R&D center in Cambridge, Massachusetts","url":"https://stock-news.laohu8.com/highlight/detail?id=2673108686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673108686?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:05","pubTimestamp":1791216345,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) today announced the opening of its newest global strategic research and development center, in Kendall Square, Cambridge, Massach...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-opens-rd-center-in-cambridge-massachusetts-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-opens-rd-center-in-cambridge-massachusetts-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","LU2456880835.USD","LU2237443622.USD","LU2417539215.USD","LU0708994859.HKD","LU0109394709.USD","AZN","LU2089984988.USD","LU2237443382.USD","LU2236285917.USD","LU2462157665.USD","LU1267930573.SGD","LU2468319806.SGD","LU2237443549.SGD","BK4007","BK4588","LU0058720904.USD","LU0310800379.SGD","AZNH","LU0289739699.SGD","XT","LU0432979614.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0320765992.SGD","LU0128525929.USD","LU0029864427.USD","BK4585","BK4568","LU2237443465.HKD","LU2237443895.HKD","KNO","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085291","title":"AstraZeneca PLC Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085291?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:01","pubTimestamp":1791216060,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC slipped 0.9% to SEK1,560.00 Monday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,595.90.This was the stock's fifth consecutive day of losses.The company closed SEK365.50 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 356,679, compared to the 50-day average trading volume of 636,482.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673108356","title":"Cboe data shows mixed options sentiment in Moderna with shares up 0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673108356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673108356?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:35","pubTimestamp":1791210909,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares up 99c, or 0.52%, near $191.00. Options volume relatively light with 15k con...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-up-0-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-up-0-52-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LGHT","BK4532","BK4501","BK4588","WDNA","BK4551","MRNA","MRNX","BK4548","BK4568","BK4533","BK4585","GNOM","MRNY","BK4139","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673651088","title":"Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2673651088","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673651088?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:58","pubTimestamp":1791208718,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  said Monday that it has received US Food and Drug Administration approval for technology that provides updates directly to patients through its CardioMEMS HF System.The company said the technology allows doctors to share daily heart pressure readings directly with patients between office visits. It said the technology also provides the ability to send medication adjustment instructions to patients' smartphones and measures pressure through an implanted sensor in the pulmonary artery.Abbott said it plans to make CardioGuide HF App and Dynamic Treatment Plan available later in the year.Price: 97.69, Change: +0.19, Percent Change: +0.19","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","LU0208291251.USD","LU2133065610.SGD","IE0009355771.USD","LU1721429402.USD","LU0170899867.USD","LU0882574055.USD","SGXZ23171101.USD","IE00B2B36J28.USD","LU0114720955.EUR","ABT.AU","LU2089984988.USD","LU1670628061.USD","LU1983299246.USD","LU0868494617.USD","LU1914381329.SGD","ABT","LU1691799644.USD","BK4581","LU2112291526.USD","LU2211815571.USD","LABU","BK4568","LU2237957902.USD","LU0070302665.USD","IHI","LU2237957811.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4566","BK4533","LU0211331839.USD","LU0432979614.USD","LU1989763427.SGD","BK4504","LU1023059063.AUD","SGXZ41872573.SGD","LU1989763690.USD","LU0058720904.USD","LU0122379950.USD","BK4592","SG9999002224.SGD","LU1061106388.HKD","BK4588","LU0289739699.SGD","TMED","LU0234572021.USD","BK4585","BK4082","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700395","title":"Abbott - Cardioguide HF App and Dynamic Treatment Plan to be Available Later This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700395?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:00","pubTimestamp":1791205204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9ZGSFT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0170899867.USD","LU0058720904.USD","BK4592","LU2468319806.SGD","BK4533","IE0009355771.USD","LU1670627923.USD","LU1670628061.USD","BK4504","TMED","IE00BJT1NW94.SGD","LU0266013472.USD","LU0432979614.USD","SG9999002232.USD","LU2237957902.USD","SGXZ41872573.SGD","LU0868494617.USD","LU2324357040.USD","SGXZ23171101.USD","BK4585","LU1989763427.SGD","LU1721429741.USD","LU0208291251.USD","LU2133065610.SGD","IE0002141913.USD","PJP","LU1061106388.HKD","LU0289739699.SGD","LU1691799644.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU0122379950.USD","LU0320765489.SGD","LU1914381329.SGD","LU2112291526.USD","LU2211815571.USD","LU1989763690.USD","LU0211331839.USD","ABT","IHI","LU0070302665.USD","LU0882574055.USD","BK4588","LU2237957811.SGD","BK4568","BK4566","IE00BJJMRZ35.SGD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673070387","title":"NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’","url":"https://stock-news.laohu8.com/highlight/detail?id=2673070387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673070387?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:50","pubTimestamp":1791204624,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) provides additional details on its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Eb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-says-phase-ii-trial-of-nv-387-in-ebola-proceeding-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-says-phase-ii-trial-of-nv-387-in-ebola-proceeding-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673170745","title":"NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Bundibugyo Ebola in DRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2673170745","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673170745?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204346,"startTime":"0","endTime":"0","summary":"NanoViricides begins Phase II trial of NV-387 oral gummies for Bundibugyo Ebola in DRCNanoViricides outlined progress in its Phase II trial of NV-387 oral gummies for Bundibugyo Ebola in the Democrati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL9Z35Qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702966","title":"Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Genmab (GMAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702966?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:50","pubTimestamp":1791201053,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE) and Genmab (GMAB). Pfizer (PFE) Citi analyst Geoff M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-and-genmab-gmab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-and-genmab-gmab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","LU0234572021.USD","LU1883839398.USD","BK4592","IE0002270589.USD","BK4007","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1894683264.USD","IE00BLSP4452.SGD","BK4139","IE000M9KFDE8.USD","LU1066053197.SGD","BK4599","LU0225284248.USD","IE00B19Z3B42.SGD","PFE","SG9999002232.USD","BK4534","LU0225771236.USD","BK4581","IE00B19Z3581.USD","LU0868494617.USD","IE00B3T34201.USD","LU1057294990.SGD","LU0122379950.USD","LU0306807586.USD","LU0170899867.USD","LU1066051498.USD","SG9999011175.SGD","BK4550","LU0321505439.SGD","BK4533","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","LU2596442595.SGD","BK4588","SG9999001176.USD","LU0306806265.USD","SG9999003800.SGD","LU1894683348.USD","SGXZ57979304.SGD","LU0321505868.SGD","BK4568","LU1023059063.AUD","GMAB","SG9999013999.USD","SG9999002224.SGD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":4,"totalSize":272,"code":"91000000","status":"200"}]}}